These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 20361940

  • 1. Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
    Zhao P, Meng Q, Liu LZ, You YP, Liu N, Jiang BH.
    Biochem Biophys Res Commun; 2010 Apr 30; 395(2):219-24. PubMed ID: 20361940
    [Abstract] [Full Text] [Related]

  • 2. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH.
    Cell Signal; 2006 Dec 30; 18(12):2262-71. PubMed ID: 16839745
    [Abstract] [Full Text] [Related]

  • 3. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH.
    J Pediatr Surg; 2004 Apr 30; 39(4):516-21. PubMed ID: 15065019
    [Abstract] [Full Text] [Related]

  • 4. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J, Ding M, Yang L, Liu LZ, Jiang BH.
    Cell Signal; 2007 Dec 30; 19(12):2487-97. PubMed ID: 17826033
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
    Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Adachi Y, Takeuchi T, Koeffler HP, Taguchi H.
    Leuk Res; 2007 May 30; 31(5):673-82. PubMed ID: 17007924
    [Abstract] [Full Text] [Related]

  • 6. A downstream kinase of the mammalian target of rapamycin, p70S6K1, regulates human double minute 2 protein phosphorylation and stability.
    Fang J, Meng Q, Vogt PK, Zhang R, Jiang BH.
    J Cell Physiol; 2006 Nov 30; 209(2):261-5. PubMed ID: 16883576
    [Abstract] [Full Text] [Related]

  • 7. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.
    Roca H, Varsos Z, Pienta KJ.
    J Biol Chem; 2008 Sep 05; 283(36):25057-73. PubMed ID: 18611860
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells.
    Zhu N, Gu L, Li F, Zhou M.
    Mol Cancer Ther; 2008 May 05; 7(5):1101-9. PubMed ID: 18483299
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y.
    Int J Oncol; 2006 Jul 05; 29(1):269-78. PubMed ID: 16773209
    [Abstract] [Full Text] [Related]

  • 10. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
    Zhong XS, Zheng JZ, Reed E, Jiang BH.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):471-80. PubMed ID: 15474452
    [Abstract] [Full Text] [Related]

  • 11. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells.
    Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC, Cheung AL.
    Carcinogenesis; 2007 Nov 12; 28(11):2313-20. PubMed ID: 17638919
    [Abstract] [Full Text] [Related]

  • 12. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L, Ruggeri A, Conte R, Cocco L.
    Leukemia; 2003 Sep 12; 17(9):1794-805. PubMed ID: 12970779
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells].
    Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Oct 12; 30(10):745-8. PubMed ID: 19173802
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway.
    Sarker KP, Lee KY.
    Oncogene; 2004 Aug 12; 23(36):6064-70. PubMed ID: 15208659
    [Abstract] [Full Text] [Related]

  • 17. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V, Bier C, Habtemichael N, Schuon R, Schweitzer A, Kunkel M, Engels K, Kovács AF, Schneider S, Mann W, Stauber RH, Knauer SK.
    Int J Cancer; 2009 May 01; 124(9):2033-41. PubMed ID: 19130609
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling.
    Skinner HD, Zheng JZ, Fang J, Agani F, Jiang BH.
    J Biol Chem; 2004 Oct 29; 279(44):45643-51. PubMed ID: 15337760
    [Abstract] [Full Text] [Related]

  • 20. VEGF-mediated survivin expression in neuroblastoma cells.
    Beierle EA, Nagaram A, Dai W, Iyengar M, Chen MK.
    J Surg Res; 2005 Jul 01; 127(1):21-8. PubMed ID: 15882878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.